One of the most significant obstacles in cancer treatment is drug resistance.  Many drugs have immediate positive effects on patients only to lose potency over time.  Because cancer cells have a unique ability to adapt, the ways in which they thwart sophisticated medicine can be different for each cancer type.  Scientists like former Damon Runyon Scholar Ramesh A. Shivdasani, MD, PhD, are working to identify how cancer cells develop this resistance and designing new methods to overcome these adaptations.

Last month, Ramesh and a team of researchers at the Dana-Farber Cancer Institute discovered how some cancer cells evade Erbitux, a commonly-used treatment for colorectal and head and neck cancers.

> Read the whole post: “Thwarting Cancer Cells’ Resistance to Treatment”